Ratio of red blood cell distribution width to platelet count as a novel parameter to predict mortality in patients with acute respiratory distress syndrome
DOI:
https://doi.org/10.63174/xdi.ZCVR6230Keywords:
red blood cell distribution width, platelet, acute respiratory distress syndrome, intensive care unit, mortalityAbstract
Background. An excessive inflammatory response and coagulation disorder promote the occurrence and development acute respiratory distress syndrome (ARDS). The ratio of the red blood cell distribution width to the platelet count (RPR) is a novel predictor of mortality in patients with ARDS. The purpose of this study was to determine the association between RPR and all-cause mortality in patients with ARDS.
Methods. This study analyzed data obtained from the Medical Information Mart for Intensive Care-III database. The clinical endpoint was 28-day mortality. Restricted cubic splines were used to determine the relationship between RPR and 28-day mortality. A Cox proportional-hazards model and subgroup analysis were used to determine the association between RPR tertiles and 28-day all-cause mortality.
Results. The 3742 included patients comprised 1128, 1384, and 1230 in the low-RPR (RPR ≤0.05), moderate-RPR (RPR >0.05 and ≤0.08), and high-RPR (RPR >0.08) groups, respectively. The mean age of the patients was 61.00 years (age range=49.00–73.00 years). Dose–response analysis indicated a V-shaped curve (nonlinear p<0.0001) between RPR and 28-day mortality in patients with ARDS. The high-RPR group had a higher mortality risk (hazard ratio=1.432, 95% confidence interval=1.176–1.743, p<0.001). The subgroup analysis indicated that RPR did not interact with other factors in the 28-day mortality of patients with ARDS.
Conclusion. These results indicated that RPR, as a convenient laboratory parameter, is of great value in evaluating the prognosis of patients with ARDS. Higher RPR is associated with increased mortality.
Published
Issue
Section
License
Articles published in X-Disciplinarity are open access and licensed under the Creative Commons Attribution–NonCommercial–NoDerivatives 4.0 International License. Under this license, authors retain copyright and grant the journal the right to publish the work while allowing others to copy and share it for non-commercial purposes, provided that appropriate credit is given and the work is not altered or transformed.